# Neurocrine Biosciences Inc: Form 8-K, filed Nov 13, 2023

- Company: [Neurocrine Biosciences Inc](/companies/nbix.md) (CIK 914475)
- Form: 8-K
- Filed: 2023-11-13
- Accepted by EDGAR: Nov 13, 2023, 07:01 ET
- Period: 2023-11-10
- Accession: 0000914475-23-000078
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/914475/000091447523000078/nbix-20231110.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/914475/000091447523000078/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/914475/000091447523000078/nbix-20231110.htm

Filed Nov 13, 2023.
Source: SEC EDGAR, the filing index for accession 0000914475-23-000078. Last ingested by Listed: Nov 11, 2026, 02:29 ET. No prices; not investment advice.